A Post-market Study Evaluating Clinical and Radiographic Outcomes of Total Elbow Arthroplasty With TEMA

Inclusion Criteria: 1. Patient's age ≥ 18 years old. 2. Patient has given written informed consent to participate to the trial and to his/her personal data processing 3. According to the device indications for use, patient suffers from disability due to one or more of the following: * Elbow joint destruction which significantly compromises the activities of daily living * Non-Inflammatory degenerative joint disease including osteoarthritis and avascular necrosis with hemophilia. * Rheumatoid arthritis or degenerative arthritis with incapacitating pain * Correction of severe functional deformity. * Treatment of acute or chronic fractures with distal humerus epicondyle involvement. * Post-traumatic lesions or bone loss contributing to elbow instability or loss of motion * Any other medical reason that the investigator determine that subject is a good candidate for a total elbow arthroplasty 4. Patient has undergone a total elbow arthroplasty, receiving TEMA prosthesis. 5. Patient is able to comply with the study protocol. Exclusion Criteria: A patient will be excluded from the study participation if he/she meets any of the following criteria: 1. Patient is affected by one or more of the conditions that are stated as TEMA contraindications for use, which are: * Local or systemic infection; * Septicemia; * Persistent acute or chronic osteomyelitis. * Uncooperative patient or patient with neurologic disorders who are incapable of following directions; * Osteoporosis; * Metabolic disorders which may impair bone formation; * Rapid joint destruction, marked bone loss or bone resorption. 2. Patient suffers from a diaphyseal fracture 3. For female patients, current pregnancy and/or lactation or planning a pregnancy. 4. Only for patients implanted with the unlinked configuration of TEMA prosthesis, the intraoperative testing showed a bad quality of medial and lateral elbow ligaments. 5. Patient is enrolled in another investigational drug/device study that in the opinion of the Investigator could interfere with this clinical trial